Eurofins Scientific SE Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 2/17/2026)
| Balance Sheet | Total Assets | 10,985,000,000.00 | ROE | 32.25 % |
| Balance Sheet | Total Equity | 3,543,000,000.00 | ROA | 4.32 % |
| Cashflow | Capital Expenditures | -760,000,000.00 | P/FCF | 27.21 |
| Cashflow | Free Cash Flow | 535,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 1,295,000,000.00 | P/CF | 11.24 |
| Income | Earnings per Share (diluted) | 2.54 | Div. Yield | 0.92 % |
| Income | Net Income | 475,000,000.00 | P/E | 30.65 |
| Income | Shares Outstanding | 187,000,000.00 | P/B | 4.11 |
| Income | Total Revenue | 7,296,000,000.00 | P/S | 2.00 |
Ratios calculated on: 10/14/2026
Company Description
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as for clinical diagnostic. It provides agroscience, agro testing, assurance, biopharma, clinical diagnostics, consumer product testing, cosmetics and personal care, environment testing, food and feed testing, forensic, genomic, maritime, materials and engineering, technologies, and REACH services. The company serves clients from a range of industries, including the pharmaceutical, food, environmental, and clinical diagnostics sectors. It operates approximately 800 laboratories in 50 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.eurofins.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more